CHINARES PHARMA (03320): Dong-E-E-Jiao's net profit for the first nine months was approximately RMB 1.328 billion, up 4.02% year on year.
China Resources Pharmaceutical (03320) announced Dong-E-E-Jiao's results for the first nine months of 2026, with total operating revenue of approximately RMB 4.94 billion, up 3.65% year on year; net profit of approximately RMB 1.328 billion, up 4.02% year on year.
CHINARES PHARMA (03320) announced Dong-E-E-Jiao's results for the first nine months of 2026, with total operating revenue of approximately RMB 4.94 billion, up 3.65% year on year; net profit of approximately RMB 1.328 billion, up 4.02% year on year.
Related Articles
CMOC Group Limited (03993): The board lot size will be changed to 500 H shares.
CHINA RISUN GP (01907) repurchased 200,000 shares on October 23 at a cost of approximately HK$311,600.
Chifeng Jilong Gold Mining (06693) reported a net profit attributable to shareholders of RMB 2.285 billion for the first three quarters, up 11.05% year on year.
CMOC Group Limited (03993): The board lot size will be changed to 500 H shares.
CHINA RISUN GP (01907) repurchased 200,000 shares on October 23 at a cost of approximately HK$311,600.
Chifeng Jilong Gold Mining (06693) reported a net profit attributable to shareholders of RMB 2.285 billion for the first three quarters, up 11.05% year on year.
